IPO registrations (S-1, F-1) · Registrants

SPECTRUM PHARMACEUTICALS INC

SEC CIK
831547 · filings on EDGAR ↗
Name on the registration
NEOTHERAPEUTICS INC
Former names
NEOTHERAPEUTICS INC (1996–2002)
Registration
Form S-1, first filed 1999-06-03, last 1999-11-10; 2 initial registrations, 3 amendments
Outcome
Final prospectus filed 1999-07-27
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
11500 S. EASTERN AVE., SUITE 240, Henderson, NV 89052
EIN
93-0979187
EDGAR entity type
operating
Insiders and CEO pay
SPECTRUM PHARMACEUTICALS INC on the corporate pages

Offering terms

Proposed price range
$4.00–$5.00 per share (S-1/A filed 1999-07-21)
Final price
$9.38 per share, above the range (424B4 filed 1999-07-27)
Shares sold
1,000,000
Gross proceeds
$9,375,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol NEOT
Lead underwriters
Joseph Charles & Assoc., Inc (400,000 shares); Millennium Financial Group, Inc (280,000 shares)
Syndicate
Financial Group, Inc; Kashner Davidson Securities Corporation (280,000); Commerzbank Capital Markets Corporation (40,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
1999-06-03S-1S-1 (registration)NEOTHERAPEUTICS INC0000892569-99-001651 ↗
1999-06-18S-1/AS-1/A (amendment)NEOTHERAPEUTICS INC0000892569-99-001739 ↗
1999-07-21S-1/AS-1/A (amendment)NEOTHERAPEUTICS INC0000892569-99-001969 ↗
1999-07-27424B4424B4 (final prospectus)NEOTHERAPEUTICS INC0000892569-99-002011 ↗
1999-10-15S-1S-1 (registration)NEOTHERAPEUTICS INC0000892569-99-002691 ↗
1999-11-10S-1/AS-1/A (amendment)NEOTHERAPEUTICS INC0000892569-99-002949 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
1999-07-21S-1/Aregistration statement$4.00–$5.001,000,000-Nasdaq NEOT1from the submission text; range, shares headline, cover names 1document ↗
1999-07-27424B4final prospectus$4.00–$5.00$9.381,000,000$9,375,000Nasdaq NEOT5from the submission text; range, price sentence, shares headline, proceeds table, underwriting table 4, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
SHROTRIYA RAJESH C MDDirector; Director,Officer; Director,Officer,TenPercentOwnerChairman & CEO; Chairman, CEO & President882006–2018
LENAZ LUIGI MDDirector; OfficerChief Scientific Officer272006–2018
KUMARIA SHYAM KOfficerSr. Vice President Finance; Vice President Finance152006–2011
Fulmer RichardDirector72007–2010
Krassner Stuart MitchellDirector262007–2019
MAIDA ANTHONY E IIIDirector442007–2019
MEHTA DILIP J MD PHDDirector62007–2011
VIDA JULIUS ADirector82007–2010
Cybulski Mitchell P.Director72007–2010
Arora Krishan KDirector52010–2012
TIDMARSH GEORGE FOfficerCSO and Head of R&D Operations; CSO AND HEAD OF R&D OPERATIONS52010–2011
Scott Brett LOfficerActing Chief Financial Officer72010–2012
Shields JamesOfficerChief Commercial Officer82010–2012
GUETH ANTONDirector32012
Gagnon GillesDirector92012–2018
Keller Joseph KennethOfficerEVP & Chief Operating Officer42012–2013
ALLEN LEE F MD PhDOfficerChief Medical Officer72013–2015
Turgeon Joseph W.Director,Officer; OfficerCEO & President; Chief Commercial Officer; President & COO402013–2021
GUSTAFSON KURT AOfficerEVP & Chief Financial Officer372013–2022
COHEN RAYMOND WDirector122013–2019
Vyas DolatraiDirector; Other162013–2022
Riga Thomas JDirector,Officer; OfficerCEO & President; Chief Operating Officer; EVP, COO & CCO; See Remarks312017–2023
Ashton WilliamDirector102018–2023
McGahan Keith MOfficerChief Legal Officer; See Remarks; SVP and Chief Legal Officer342018–2023
Welles Bernice RDirector52018–2021
Vacirca Jeff LDirector212018–2023
LEBEL FRANCOISOfficerChief Medical Officer162019–2022
CZEREPAK ELIZABETHDirector32019–2020
Fischer Seth H. Z.Director72020–2023
Brennan NoraDirector; OfficerCFO; EVP & CFO; See Remarks72020–2023
Lim JuhyunDirector42022–2023
Bradrick BrittanyDirector32022–2023

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2016-04-28SPECTRUM PHARMACEUTICALS INCPharmaceuticals$3,000,000$3,000,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationSPECTRUM PHARMACEUTICALS, INC.ILState business registriesEIN (EXACT, as the state registration reports it)
Plan sponsorSPECTRUM PHARMACEUTICALS, INC.CAForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerSPECTRUM PHARMACEUTICALS INCNVForm D private offeringsCIK (EXACT)
Lobbying clientSPECTRUM PHARMACEUTICALSNVFederal lobbying (LDA)name and state
Lobbying clientSPECTRUM PHARMACEUTICALS, INCNVFederal lobbying (LDA)name and state
Lobbying clientSPECTRUM PHARMACEUTICALS, INCNVFederal lobbying (LDA)name and state
Lobbying clientSPECTRUM PHARMACEUTICALS, INC.NVFederal lobbying (LDA)name and state
Paying companySpectrum Pharmaceuticals Inc.NVOpen Payments (drug and device company payments)name and state
SEC filerSPECTRUM PHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerSpectrum Pharmaceuticals, Inc.NVTrademarks (USPTO)name and state
Form 5500 plan sponsorSPECTRUM PHARMACEUTICALS, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NV first:

More with this interest.

In other datasets, the same topic (Health) in NV:

Interests: Pharmaceutical Preparations · Health